Tonix Pharmaceuticals Holding Corporation【TNXP】株式ニュース

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Real-world analysis of three years of closed claims data from Symphony Health, focused on the third year of the...

Form 8-K - Current report

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

Phase 1 data support TNX-1500 as a potentially first-in-class, best-in-class, third-generation anti-CD40L...

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

BERKELEY HEIGHTS, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP...

Tonix Pharmaceuticals to Participate in Two Investor Conferences in May

BERKELEY HEIGHTS, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

OnTrack444 4日前

And yet it continues to sink…. Diluting machine here ever since that RS! This was the playbook all along! Sad but true!

👍️0

techno53 1週前

What is tonix at now?? You spelled bullshit wrong DA!!!!

👍️0

timberwolf7 2週前

Well some of us have. Not too long ago:

3 Oct 2025: float 8.86 Mil Inst 15%

3 Nov 2025 float 11.8 Mil Inst still at 15%
but that means they bought 15% or so of the
additional 3 Mil shares to keep the holding at 15%

25 Nov 2025 float 11.8 Mil, insts 20%

12 Mar 2026 float at 12.8 Mil, insts 29% (see the 3 Nov note)

and now per Yahoo data, 15.9 Mil shares Insts 35%
(again, see the 3 Nov note regarding the relationship)

Yep, almost like wall street knows how to win isn't it. Price appreciation
muted, insts % increases with shares 'cheap' to buy.. Funny how that works
isn't it. But its also why one should track the insts holding %... Would really be
nice to see it push over 50%. Lock up more and more of the float and those that
want to short it to drive it lower? Going to get more and more warier to want to try.

Good luck... PS Market cap this morn around $208 Million The initial market cap
I have been using is $550 Mil. Means I will have to be 'happy' to see a share price of
around $32/sh...And will be looking to see what market cap wall street gives them when
they cross the 100,000 user threshold..

👍️0

insidernews 2週前

Have people not noticed that financial institution have been buying crazy for the past 5 months

👍️0

techno53 2週前

The stock price is down DA!!! After the reverse split, the stock price will sink like the titanic!!! LOL!!!!

👍️0

timberwolf7 3週前

Well if your 1 for 250 is as accurate as your
21 April call on OTLK???

Call me not too worried (smile)

Although given your 'positive' messaging here about
TNXP for a bit of time now? Did YOU decide that when
they posted about wanting the authority to do a r/split?
You went short on some shares??

👍️0

Stino2 3週前

techno53, so 250*15 = 3750 for one, you see aliens or something ??????? 🤪

👍️ 1

Stino2 3週前

techno53, bulshit man, in a few months Tonix will go break-even and then go ⬆️

👍️ 1

techno53 3週前

When the 1:250 reverse split happens the stock price will sink like the titanic!!!

👍️0

Stino2 3週前

next week TRx>800 NRx>600 and the stockprice >17$ if Tonix is going break even the stockprice> 500$ 😇

👍️ 1

Stino2 3週前

Wait until the 38 states with Medicaid are added and also 35 million patients with GPO, this will 💪 rocket the sales these are facts and not bulshit from then bears,

👍️ 1

Frankestin 1月前

Tonix partners with GPO to secure TONMYA coverage for 35 million US commercial lives
OHhhhhhhhhhh

👍️ 1

timberwolf7 1月前

TD Cowen initiates coverage of Tonix, target price
$22..

Call it a 'start'. hmmm

👍️0

timberwolf7 1月前

On STOCKTWITS, being reported that Tonix
has put out a preliminary report. Worst of it is that
they diluted again in April. Burning cash and dilution
is NOT a good combination for shareholders.
Maybe why the intent of the reverse split vote is becoming
clearer if they are going to keep doing this. Cause the 102
development is all they have going for them for quite a while
in terms of a source of revenue... Not good..

News regarding Pfizers Lyme disease development: Given that its
pfizer? Not sure how much I trust their 'claims' after the covid mess/lies.
And not sure I like the idea of having to keep getting boosters to keep its
effectiveness up as I am not a fan of pumping chemicals into myself..
But it is 'first' to market, so if TNXP is going to keep pushing their development?
They better be 'better' if they want market share...

https://www.sciencenews.org/article/lyme-disease-vaccine-ticks-infection
dated 20 April 2026

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-valneva-announce-lyme-disease-vaccine-candidate
23 Mar 2026

👍️0

timberwolf7 2月前

OTLK? Why buy it now?? Cause 3 months ago
the fda told them via a CRL that they need more
EVIDENCE before they can expect their NDA submission
to be accepted.

They have nothing else to offer at this stage of their lifespan..

Not a recipe for one that should be 'bought' unless you are
fast trading/a momentum trader taking what you can get from it.

👍️0

insidernews 2月前

Congratulations your down 10%. This is not a airport no need to announce your departure. The jokes write themselves

👍️0

techno53 2月前

Take a look at OTLK it is moving up fast. I made up most of my losses from tonix. Good luck trading.

👍️0

Stino2 2月前

Why make a fush about things, let everybody thinks what he or she wants, it's a free world or not 😇

👍️0

insidernews 2月前

You must be new to biotech. Dilution is normal for biotech company raising money for sales Force and experimental drugs. It went from $7 to $70. If they sold at in the higher price range to raise money that was a great opportunity. The market knew it was highly likely that the drug was going to be approved. It was a buy the rumor sell the news. Maybe you should buy a cd or put your money in a savings account. You said you sold. Bye be gone! Your opinion doesn't matter. Maybe you should express your thoughts to black rock! I'm sure Larry fink would sell if he knew your thoughts. Clown 🤡

👍️ 1 ☺️ 1

techno53 2月前

You are either working for an investment firm, tonix or you must be very stupid. First of all DA. this company has produced almost nothing in income so far!! They can't manage their way out of a paper bag!! Schwab gives then a rating of "F" for a good reason!!
The stock price was at $70 per share and could have gone higher. What did Seth and his cronies do, they dumped shares into the market and diluted the stock!!
Seth and his cronies are using this company as their own personal ATM!!
After the reverse split of 1:250 is authorized by Seth and cronies, watch your shares disappear NN!! I will appear on this board or other boards anytime I feel like it. You don't like it, then GFY!!!!

👍️0

insidernews 2月前

Black Rock, vanguard, State Street and point72 asset management have all bought in the past 2 months. Bye and don't come back

👍️0

insidernews 2月前

Black Rock, vanguard, State Street and point72 asset management have all bought in the past 2 months. Bye and don't come back

👍️0

Stino2 2月前

Why should they do a RS, that's negative for the most investors???

👍️0

timberwolf7 2月前

Someone i know got their 'vote' notice a while ago. We
got ours the day before yesterday via email... from Schwab...

So would think your brokerage would either send you a notice to
vote, or maybe its in your messages in your account??

Cause TNXP isn't giving us a heck of a lot to talk about??

I did vote NO on the latest proxy, against the r/split even tho
I can see their what I will call PRO-ACTIVE move to put the
'tool' in place in the event the share price tanks (describing
how I read their rationalization for why they would like to have
the r/split authorization in place).

But voted NO because I am tired of the dilution they have been
quietly doing and have authorization to keep doing if so inclined.

and there is news this morn (see the NEWS feed right side of
this webpage). But again, until they give us something to
discuss? AKA, the uptake on the usage of... Just not a lot
to comment on except that we are waiting to see if the uptake
ramps up.

Oh yeah, caught something on STOCKTWITS that something named
AGP came out and reaffirmed a $65 target price. Still waiting to see if
anyone else is going to 'update' their analysis, but guessing they are
like us. Waiting for the info they need to be able to do so..

Good luck

disclaimer: did add a very small amount down in the $14 range, but
couldn't do anymore than that due to the lack of communication and
insights into what they are seeing.

👍️0

techno53 2月前

Time to exit tonix. All that Seth and his cronies are doing is dumping shares into the market and then executing reverse splits!! This company should be investigated by the SEC!! There is no positive growth that this company has produced!! All the actions from Seth and his cronies are reverse splits. Not one forward split or shares buy back!!! They are using it for their own ATM to pay the multi million dollar salaries!! I am out of this POS!!!

👍️0

Stino2 2月前

Why does nobody post anything here ???

👍️0

timberwolf7 2月前

share count now up to 14.2 Mil, up from 12.8 on 3/12/26

SOBs keep raising cash, diluting. Market cap as of a few minutes
ago now under $200 Million...

My target price based on a reasonable $550 Mil market cap, with the
14.2 Mil shares? Now at $38/sh Nice return from this level, but sucks
for those with shares bought over $25 (approaching a less than 50% return)

Heres hoping sales ARE ramping up... as some of us expected IF this helps
as the trials indicate it has the potential to do so..

👍️0

Frankestin 2月前

interesting price, Seth bought it but the earnings need to grow because he already said he will spend a lot... well I'll take some, in my opinion lean times are coming for the owls
Tonix is scheduled to present Phase 1 data on TNX-4800 at World Vaccine Congress Washington 2026 on March 30, 2026.
Data on TNX-801 is set to be presented at the same conference on April 1, 2026.
Christopher Cooper is scheduled to moderate a panel on poxvirus antigen-delivery systems on April 1, 2026.

👍️0

Stino2 2月前

Why always so negative, that doesn't help you know, the sales are up and maybe from april it will go faster because of the big insurance company UHC, lets hope for the best instead of always 👎️👎️, it has to be 💪

👍️0

Dumb&dumber4long 2月前

TNXP was not able to set a higher high on the yr/d chart, instead it set a lower low, not a good sign.
However, the markets took a hit while tnxp was holding up, until Friday!
Short interest increased by 20% to 2.47 million shares, more fuel for the next leg up.
Waiting on Tonix, news/data to push it above 19!
2.5 months to the next earnings report, but 1st the May meeting.

👍️0

timberwolf7 2月前

The legal fleecing is their spending money on developments
they really can't afford at the moment.

Especially for those with existing competition already in the market
The Lyme disease vaccine I am all for progressing cause I am aware
of some who have gotten it, and didn't realize it till it was too late.

As for the r/split, they want a 2 year window which is the amazing part and
predicated on an 'as needed' basis with the chatter about holding the share price
up to stay listed on the NASD.

Yesterday was the first time I have written a nasty message to a companys management
requesting they get their fiscal house in order.

I do expect the fibro development to get traction because its needed. So even asking for
the r/split at this stage was an eye opener.

Unless of course, they are trying to shake as many shares loose from the retail sector
for deeper pockets as they can.

For the institutionals hold 28% of the 13.4 at the moment. And given the potential for this to
move higher IF sales ramp up? I can see them wanting more shares.

Don't know, but it was a shocker to see them asking for a r/split authorization at this stage
with a comment being, can management really be this inept at this stage of the game??

And if not, what are they really planning to do??

disclaimer: I am going to hold on, can't forget seth just put some of his own money to work..

👍️0

Dumb&dumber4long 2月前

WTF is with Tonix hooked on reverse splits.
Legal fleecing of stockholders!
Look at the 5 year chart, $900,000 value down to $14. How many investors got burned.
20 year chart, $9,600,000,000 wasted down to $14.
We, as many splits before us, are hoping things will change.
But, is hope a good investment strategy!
Let’s hope this time investors will not approve another reverse splits!
What’s the deadline for the currently approved reverse! Does it expire before or after the next meeting?
You know the reason for this question!

👍️0

timberwolf7 2月前

TNXP floats a PRE-LIMINARY proxy for May 7th. Linke
to it in their SEC filings on their website.

In it? They indicate they want the authority to conduct a
reverse split IF/AS needed in the next 2 years.

1st time I sent a company a nasty email telling them its time to
put some of their trials on 'hold' and focus on just one or two
while they work to ramp up sales.

But enough of the damn dilution already and stop blowing
thru the $200 Million they have on hand..

👍️0

timberwolf7 3月前

Due Diligence tips??

-development is approved
-it reportedly works per the PH 3 clinical trials
(how long it will remain effective for those taking is another question)
-there is currently nothing on the market that has a good success rate
with respect to helping folks who NEED something that works to relieve
their pain
-there are reportedly around 10 Million who could 'benefit' from this development
-sales have just commenced
-a very rough conservative estimate because I have no idea what the company will actually get in terms
of revenues/profits from every 100,000 users getting monthly subscriptions. But figure for
every 100,000 users, over a 12 month period? They might see a $20 increase per share.
-especially with their low share count of around 13.4 Million shares
-cash on hand is reportedly $200 Million, enough to get into 2027
-and reportedly the ones who are likely to subscribe this development is quite 'concentrated' meaning
IF it works, the uptake could be 'interesting'..

Biggest concerns? -they are bleeding cash heavily before this one proves it has legs (ie, been diluting way too much)
-how long will it remain effective for those that need it, start taking it.. Because its recognized,
some developments do lose their effectiveness with time and the bodys reaction to its usage

Is this what you were looking for??

👍️0

rbtree 3月前

Nice move today and this week! Aware of the co. but have never followed it.
Came over as you mentioned it to me earlier elsewhere.
Got DD tips?

👍️0

timberwolf7 3月前

My charting software has been indicating TNXP just needed a bit of 'sustainable' good news and it could come off
its recent lows.

Figured the news of the sales data, the NEED for it and how many COULD benefit from it was what
the market was waiting to hear.

This will 'help'... get it some attention...

👍️ 1

Dumb&dumber4long 3月前

Is this what moving tnxp today!
https://www.tipranks.com/news/insider-trading/tonix-pharma-ceo-makes-bold-insider-move-signaling-growing-confidence-insider-trading-news?mod=mw_quote_news

👍️0

timberwolf7 3月前

Wow, TNXP leadership can talk publicly (LOL)

https://investorshub.advfn.com/stock-market/NASDAQ/tonix-pharmaceuticals-TNXP/stock-news/98089701/tonix-pharmaceuticals-to-present-at-bio-europe-spr

👍️0

timberwolf7 3月前

So is this earnings release, proof that sales have commenced,
the TURNING point for TNXP going forward??

It MAY turn out to be... cause one would expect the sales to
ramp up IF this really helps folks.

👍️0

timberwolf7 3月前

Doesn't look like TNXP is going to hold a conference call (??)

Unless they announce something going forward? Don't see
anything advertised on their website, just an 'updated' March
2026 presentation. Interesting.

👍️0

Dumb&dumber4long 3月前

No, I won’t.
You’re ignored.
Write all want.

👍️ 1

infamous 3月前

You can ignore all yu want. But when you see TNXP at 6.50, you'll remember me.

👍️0

Dumb&dumber4long 3月前

You’re being very kind to infamous!
Infamous by definition means “known for Bad Quality”
I was tempted to give my opinion, then I decided to restrain this time.
He may end up on the Infamous Gallery!
My ignore list.

👍️ 1

infamous 3月前

It says...THIS WILL GO BELOW 6.50

👍️0

timberwolf7 3月前

Not sure what 'its' agenda is, but looking at some of
its messages?

Not someone I would consider taking advice from..

👍️0

Dumb&dumber4long 3月前

Calling people on this board Dummies is not cool.
You sound like a dummy yourself.
Buying ITM 1 year out call options when tnxp is at $6.50 is a dummy’s plan.
Tnxp volatility is around 100%.
You’d be better off buying the stock, no expiration date.
Or you think buying $6 call 1 year out is going to be less money!
Enough to justify taking a trade with an expiration date, rather than owning the stock @ $6.50
FYI,
Tnxp now has only 6 months out options & for the 6 months ITM $12.50 September ‘25 calls the asking price is $8.
What do you think it would’ve been for 12 months out!
Apply to your plan to get $6 ITM I year to exp call options when it’s trading @ $6.50
The good part, you have plenty of time to think it over.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Tonix Pharmaceuticals Holding Corporation (TNXP)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Tonix Pharmaceuticals Holding Corporation (TNXP) ニュース

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Form 8-K - Current report

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

Tonix Pharmaceuticals to Participate in Two Investor Conferences in May

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

TNXP Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Tonix Pharmaceuticals Holding Corporation (TNXP)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Tonix Pharmaceuticals Holding Corporation (TNXP) ニュース

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Form 8-K - Current report

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

Tonix Pharmaceuticals to Participate in Two Investor Conferences in May

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

TNXP Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する